Allergy Therapeutics announces plans to delist from AIM, shares fall
(Alliance News) - Allergy Therapeutics PLC shares on Tuesday plunged after the company said it intends to delist from AIM. Read More
| Price | 1.30p on 05-11-2026 at 05:12:20 |
|---|---|
| Change | 0.00p 0% |
| Buy | 1.50p |
| Sell | 1.25p |
| Last Trade: | Sell 22,333.00 at 1.30p |
| Day's Volume: | 0 |
| Last Close: | 1.30p |
| Open: | 0.00p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 1.25p - 12.10p |
| Market Capitalisation: | £82.32m |
| VWAP: | 0.00p |
| Shares in Issue: | 6.33b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 22,333 | 1.30p | Uncrossing Trade |
16:35:20 - 04-Nov-26 |
| Sell* | 5,000 | 1.282p | Ordinary |
16:11:25 - 04-Nov-26 |
| Sell* | 2,000 | 1.282p | Ordinary |
16:10:57 - 04-Nov-26 |
| Buy* | 100,000 | 1.385p | Ordinary |
16:09:33 - 04-Nov-26 |
| Sell* | 100,000 | 1.28p | Ordinary |
16:04:33 - 04-Nov-26 |
| Unknown* | 700,000 | 1.26p | Ordinary |
14:49:10 - 04-Nov-26 |
| Sell* | 4,509 | 1.26p | Ordinary |
14:37:01 - 04-Nov-26 |
| Sell* | 35,714 | 1.276p | Ordinary |
14:32:23 - 04-Nov-26 |
| Sell* | 11,569 | 1.25p | Ordinary |
14:10:57 - 04-Nov-26 |
| Sell* | 23,254 | 1.276p | Ordinary |
13:13:40 - 04-Nov-26 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Nov 2026 7:00 am | RNS | Proposed Cancellation of Admission |
| 29th Jul 2026 7:00 am | RNS | Trading update for the year ended 30 June 2026 |
| 28th Jul 2026 7:00 am | RNS | Appointment of Executive Chairman |
| 30th Jun 2026 7:00 am | RNS | Vesting of Options under Long-Term Incentive Plan |
| 15th Jun 2026 7:00 am | RNS | Long Term Incentive Awards |
| 12th Jun 2026 7:00 am | RNS-R | Allergy Therapeutics to present at EAACI 2026 |
| 31st Mar 2026 7:00 am | RNS | Interim Results for six months ended 31 Dec 2025 |
| 12th Mar 2026 7:00 am | RNS | PDMR Dealings & Shareholding Update |
| 12th Mar 2026 7:00 am | RNS | PDMR Dealings & Shareholding Update |
| 4th Mar 2026 7:00 am | RNS | Positive Biomarker Results from PROTECT Trial |